The uncrontolled division of cancer cells leads to the carcinogenesis.
The uncrontolled division of cancer cells leads to the carcinogenesis.
For the first time, researchers have estimated what percentage of cancer mutations are due to environmental and lifestyle factors, hereditary factors and random chance. Overall, 66% of the genetic mutations that develop into cancer are caused by simple random errors occurring when cells replace themselves, according to a new study published in the journal Science.
Environmental factors contribute 29% of mutations, while the remaining 5% are inherited, say Cristian Tomasetti and Dr. Bert Vogelstein, both of Johns Hopkins University.
In a previous paper, Tomasetti and Vogelstein asserted that your risk of developing cancer is largely based on random DNA errors that occur when self-renewing cells divide. In their new paper, they offer more detail describing how dumb luck plays a more significant role than either environmental, lifestyle or hereditary factors in causing this disease.
Every time a perfectly normal cell divides, as you all know, it makes several mistakes mutations, explained Vogelstein in a briefing. Now most of the time, these mutations dont do any harm. They occur in junk DNA, genes unrelated to cancer, unimportant places with respect to cancer. Thats the usual situation and thats good luck.
Occasionally, one of these random miscopies will occur in a cancer driving gene.
Thats bad luck, said Vogelstein.
Though this fact may be demoralizing to some people, researchers noted it might bring comfort to people with cancers they worked to prevent or the parents of children with cancer.
Your lifestyle still matters
In a previous research paper published in 2015, Tomasetti and Vogelstein used a mathematical model to first present this idea that cancer risk is strongly correlated with the total number of divisions undergone by normal cells. For 31 cancers, the researchers first estimated the number of stem cells in tissues where disease arose and then they estimated the rate at which these cells divide. Comparing these to incidence of these cancers in the United States, the two researchers found a strong correlation between cell division and lifetime risk of each given cancer.
For their new study, Tomasetti and Vogelstein worked with Lu Li, a doctoral student at Johns Hopkins Bloomberg School of Public Health, to analyze genome sequencing and epidemiologic data from 32 cancer types, including breast and prostate cancers. This time, the research team concluded that nearly two-thirds of mutations in these cancers are attributable to random errors that occur naturally in healthy, dividing cells during DNA replication.
Drilling deeper, they searched 423 international cancer databases to examine data from 69 countries spanning 6 continents, representing 4.8 billion people or two-thirds of the worlds population. Then, as theyd done in their previous study, they estimated stem cell divisions in different human tissues and compared this to lifetime incidence of 17 cancer types.
Once again, their new mathematical model showed a high correlation between cancer incidence and the total number of divisions of normal cells. This time, though, their finding that 66% of all genetic mutations leading to cancer are caused by random errors crossed borders and so ranged across many different potential environmental factors that might lead to cancer.
While this randomness is upsetting, even mutations caused by environmental or lifestyle factors are haphazard, explained Tomasetti.
Take smoking: Cigarette smoking undoubtedly leads to more genetic mutations than might normally happen, yet where the DNA defects occur on a smokers genome is completely accidental. In other words, mutations caused by smoking, just like random mutations, can affect either cancer driving genes or stretches of DNA that are irrelevant to cancer.
Lifestyle factors still matter for cancer prevention.
Just one mutation is not sufficient to cause cancer typically three or more mutations must occur, Tomasetti noted. If, say, your cells miscopy DNA and so cause two random mutations, a third mutation is still needed. Obesity, smoking, lack of exercise and poor eating habits might supply that necessary third gene defect that tips your body into a disease state.
The new study, then, does not let us off the hook: We play a role in protecting our good health.
Paradigm shift
Since the 1970s, the accepted wisdom underlying cancer research was that genomic alterations caused cancer and most of these alterations are mutations, explained Tomasetti. As envisioned by scientists, DNA defects cause the haywire growth of cells which disturb the natural processes of your body.
Naturally, that leaves one fundamental question: What causes these mutations?
Widespread belief suggests the majority of cancers are caused by behavioral and environmental factors, with inherited genetic mutations causing the remainder of cases.
This is the current paradigm and we feel that our new research breaks this paradigm, said Tomasetti. We discovered theres a third factor that actually causes most of the mutations random errors made during normal cell division.
So why was this never appreciated before? It was never measured before and when you measure something you can have a sense of how important that is, said Tomasetti.
In an editorial published alongside the new study, Martin A. Nowak, a professor of mathematics and biology at Harvard University, and Bartlomiej Waclaw, a researcher at University of Edinburgh, wrote that a large portion of the variation in cancer risk among tissues can be explained, in the statistical sense, by the number of stem cell divisions.
An understanding of cancer risk that did not take bad luck into account would be as inappropriate as one that did not take environmental or hereditary factors into account, Nowak and Waclaw wrote.
While Tomasetti and Vogelsteins first paper led to no less than a few hundred papers written in response, their new study appears to be more soothing to the nerves.
Answers for those who did everything right
I was concerned about the last article, because it didnt talk enough about prevention and it left people thinking, Gee youre just destined to get cancer and you cant do anything about it,' said Dr. Otis Brawley, chief medical officer of the American Cancer Society. Brawley, who was not involved in the research said he was much happier with the current paper, even if it doesnt tell me anything I hadnt known for the last 20 years.
Bert Vogelstein is an incredibly well-respected, well-known cancer biologist who published a paper very similar to this you might even call it part one of this paper two years ago, said Brawley, explaining the original paper caused quite a stir because it implied that almost all cancers were not preventable.
And it really upset the anti-smoking people, it upset the folks who are in the nutrition and physical activity for cancer prevention he really upset the prevention crowd, said Brawley, who believes the new paper is generally a better explanation of the original theory.
Keep in mind its a mathematical simulation, its not a clinical trial, but [Vogelstein is] noting that a certain number of cases are due to replication error, DNA replication error, in normal growth, said Brawley. Those are cancers we really cannot do a lot to prevent.
Brawley described counseling a 47-year old woman who said shed done everything right: She ate healthy, exercised, didnt smoke and got yearly mammograms. Despite having a clean mammogram just six months earlier, she was diagnosed with stage 4 breast cancer.
How did this happen to me? she asked Brawley.
The answer is she had a replication error, said Brawley. And the way you think about replication error is DNA is always being copied throughout your body a million times every day, you know, cells die off and cells are replaced. We have mitosis and an important thing in cell duplication or mitosis is DNA is replicated or copied and the DNA is supposed to be copied exactly and occasionally theres a misreplication or miscopying.
Brawley appreciates the fact that Tomasetti and Vogelstein acknowledge the past controversy and make a point in their new paper of addressing prevention and detection.
I think that we need to have a balance between cancer prevention efforts as well as what I would call wise early detection or wise screening efforts, said Brawley.
Theres a tendency in the US to think that every screening test is great. Unfortunately there are screening tests that actually cause more harm than good, said Brawley.
In the 1960s and 1970s, we stopped doing chest X-ray screening for lung cancer because, after 20 years of doing it, we finally got around to doing an assessment and we found the death rates were higher in the screened versus the unscreened group, said Brawley. The reason? When a patients chest X-ray was found to be abnormal, the follow-up biopsy might cause a collapsed lung or heart attack, he explained.
We still have huge debates whether theres a benefit to prostate cancer screening. There, the benefit might be to a subset of men and not to all men thats an unknown, thats a question mark, said Brawley.
When it comes to mammography screening, thats something all of us believes saves lives but its not perfect, said Brawley.
The best studies that we have show that mammography reduces risk of death by 30%, said Brawley. That means if you have a group of women who habitually get screened, get good high quality screening, mammography is not going to help 70%.
According to Vogelstein, the new study is important for two reasons.
We hope this research offers comfort to the literally millions of patients who have developed cancer but have led near perfect lifestyles, said Vogelstein. Non-smokers who have avoided the sun, these cancer patients eat healthy diets, exercised and done everything to prevent cancer. But they still get it, said Vogelstein.
Its important, especially for parents of children who have cancer, that people understand the root causes of cancer.
The first thing someone looking on the web would see is cancer is caused by environment or heredity, said Vogelstein. When it comes to the parent of a child with cancer, they think they either transmitted a bad gene or exposed their child to an environmental agent that caused disease.
This causes a tremendous amount of guilt, said Vogelstein, who is also a pediatrician and has seen such cases. We dont need to add guilt to an already tragic situation.
The second reason the study is important is because cancer will strike about 1.6 million people in the United States this year. And it will kill 600,000 of us, said Vogelstein. We need a completely new strategy.
He hopes new awareness of these random mutations will inspire many scientists to devote their efforts to various strategies to limit the damage that these internal enemies do.
The first step is simply recognizing these enemies exist, said Vogelstein.
See original here:
'Bad luck' mutations increase cancer risk more than behavior, study says - fox5sandiego.com
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021